BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331-45. [PMID: 32601832 DOI: 10.1007/s13238-020-00745-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Haskey N, Ye J, Estaki M, Verdugo Meza AA, Barnett JA, Yousefi M, Birnie BW, Gruenheid S, Ghosh S, Gibson DL. A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model. Gut Microbes 2022;14:2055441. [PMID: 35471119 DOI: 10.1080/19490976.2022.2055441] [Reference Citation Analysis]
2 Zhang Y, Li CX, Zhang XZ. Bacteriophage-mediated modulation of microbiota for diseases treatment. Adv Drug Deliv Rev 2021;176:113856. [PMID: 34237403 DOI: 10.1016/j.addr.2021.113856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Chen Z, Luo J, Li J, Kim G, Chen ES, Xiao S, Snapper SB, Bao B, An D, Blumberg RS, Lin CH, Wang S, Zhong J, Liu K, Li Q, Wu C, Kuchroo VK. Foxo1 controls gut homeostasis and commensalism by regulating mucus secretion. J Exp Med 2021;218:e20210324. [PMID: 34287641 DOI: 10.1084/jem.20210324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sheikh SW, Ali A, Ahsan A, Shakoor S, Shang F, Xue T. Insights into Emergence of Antibiotic Resistance in Acid-Adapted Enterohaemorrhagic Escherichia coli. Antibiotics (Basel) 2021;10:522. [PMID: 34063307 DOI: 10.3390/antibiotics10050522] [Reference Citation Analysis]
5 Pakbin B, Brück WM, Rossen JWA. Virulence Factors of Enteric Pathogenic Escherichia coli: A Review. Int J Mol Sci 2021;22:9922. [PMID: 34576083 DOI: 10.3390/ijms22189922] [Reference Citation Analysis]
6 Lu Q, Yang M, Liang Y, Xu J, Xu H, Nie Y, Wang L, Yao J, Li D. Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. JIR 2022;Volume 15:1825-44. [DOI: 10.2147/jir.s353038] [Reference Citation Analysis]
7 Feng C, Zhang W, Zhang T, Li B, He Q, Kwok L, Zhang H. Oral administration of pasteurized probiotic fermented milk alleviates dextran sulfate sodium-induced inflammatory bowel disease in rats. Journal of Functional Foods 2022;94:105140. [DOI: 10.1016/j.jff.2022.105140] [Reference Citation Analysis]
8 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
9 Wang R, Wang D, Wang H, Wang T, Weng Y, Zhang Y, Luo Y, Lu Y, Wang Y. Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis. Front Immunol 2021;12:670159. [PMID: 34456904 DOI: 10.3389/fimmu.2021.670159] [Reference Citation Analysis]
10 Schierova D, Roubalova R, Kolar M, Stehlikova Z, Rob F, Jackova Z, Coufal S, Thon T, Mihula M, Modrak M, Kverka M, Bajer L, Kostovcikova K, Drastich P, Hercogova J, Novakova M, Vasatko M, Lukas M, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells 2021;10:3188. [PMID: 34831411 DOI: 10.3390/cells10113188] [Reference Citation Analysis]
11 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Wu Y, Shen J. Innate Lymphoid Cells in Crohn's Disease. Front Immunol 2020;11:554880. [PMID: 33329513 DOI: 10.3389/fimmu.2020.554880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Mo Q, Liu T, Fu A, Ruan S, Zhong H, Tang J, Zhao M, Li Y, Zhu S, Cai H, Feng F. Novel Gut Microbiota Patterns Involved in the Attenuation of Dextran Sodium Sulfate-Induced Mouse Colitis Mediated by Glycerol Monolaurate via Inducing Anti-inflammatory Responses. mBio 2021;12:e0214821. [PMID: 34634946 DOI: 10.1128/mBio.02148-21] [Reference Citation Analysis]
14 Larussa T, Abenavoli L, Fabiano G, Mancuso MA, Polimeni N, Dumitrascu DL, Luzza F. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.21.02907-7] [Reference Citation Analysis]
15 Khan IA, Nayak B, Markandey M, Bajaj A, Verma M, Kumar S, Singh MK, Kedia S, Ahuja V. Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis. PLoS One 2021;16:e0256098. [PMID: 34407136 DOI: 10.1371/journal.pone.0256098] [Reference Citation Analysis]
16 Qiu Y, Yang J, Wang L, Yang X, Gao K, Zhu C, Jiang Z. Dietary resveratrol attenuation of intestinal inflammation and oxidative damage is linked to the alteration of gut microbiota and butyrate in piglets challenged with deoxynivalenol. J Anim Sci Biotechnol 2021;12:71. [PMID: 34130737 DOI: 10.1186/s40104-021-00596-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Tian Y, Zhang D, Nakamura M. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/2939921] [Reference Citation Analysis]
18 Han MM, Yuan XR, Shi X, Zhu XY, Su Y, Xiong DK, Zhang XM, Zhou H, Wang JN. The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Front Pharmacol 2021;12:732790. [PMID: 34539413 DOI: 10.3389/fphar.2021.732790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Chen M, Fan H, Chen X, Yi Y, Zhang J, Zhu J. Alterations in the saliva microbiome in patients with gastritis and small bowel inflammation. Microbial Pathogenesis 2022;165:105491. [DOI: 10.1016/j.micpath.2022.105491] [Reference Citation Analysis]
21 Di Ciaula A, Stella A, Bonfrate L, Wang DQH, Portincasa P. Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF). Genes (Basel) 2020;11:E1041. [PMID: 32899315 DOI: 10.3390/genes11091041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets 2020;24:1263-82. [PMID: 33180654 DOI: 10.1080/14728222.2020.1841749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Cui X, Wang H, Ye Z, Li Y, Qiu X, Zhang H. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms. BMC Gastroenterol 2021;21:433. [PMID: 34798830 DOI: 10.1186/s12876-021-02015-w] [Reference Citation Analysis]
24 Lee DJ, Lee HJ Jr, Farmer JR, Reynolds KL. Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors. Curr Cardiol Rep 2021;23:98. [PMID: 34196833 DOI: 10.1007/s11886-021-01530-2] [Reference Citation Analysis]
25 Franzin M, Stefančič K, Lucafò M, Decorti G, Stocco G. Microbiota and Drug Response in Inflammatory Bowel Disease. Pathogens 2021;10:211. [PMID: 33669168 DOI: 10.3390/pathogens10020211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Curciarello R, Canziani KE, Salto I, Barbiera Romero E, Rocca A, Doldan I, Peton E, Brayer S, Sambuelli AM, Goncalves S, Tirado P, Correa GJ, Yantorno M, Garbi L, Docena GH, Serradell MLÁ, Muglia CI. Probiotic Lactobacilli Isolated from Kefir Promote Down-Regulation of Inflammatory Lamina Propria T Cells from Patients with Active IBD. Front Pharmacol 2021;12:658026. [PMID: 33935778 DOI: 10.3389/fphar.2021.658026] [Reference Citation Analysis]
27 Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H, Zhang Y, Ma C, Ding J, Hua K. Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health. Front Endocrinol 2022;13:808508. [DOI: 10.3389/fendo.2022.808508] [Reference Citation Analysis]
28 Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis 2022;14:e1540. [PMID: 35266651 DOI: 10.1002/wsbm.1540] [Reference Citation Analysis]
29 Yang Q, Ouyang J, Pi D, Feng L, Yang J. Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis. Front Immunol 2022;13:846469. [DOI: 10.3389/fimmu.2022.846469] [Reference Citation Analysis]
30 Starz E, Wzorek K, Folwarski M, Kaźmierczak-Siedlecka K, Stachowska L, Przewłócka K, Stachowska E, Skonieczna-Żydecka K. The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn's Disease. Nutrients 2021;13:2125. [PMID: 34206152 DOI: 10.3390/nu13072125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Lee B, Lee JY, Kim J, Shin N, Yoo JM, Kang I, Kim J, Lee S, Kim D, Choi SW, Hong BH, Kang K. Oral administration of microbiome-friendly graphene quantum dots as therapy for colitis. 2D Mater 2021;8:025036. [DOI: 10.1088/2053-1583/abe362] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Bethlehem L, van Echten-Deckert G. Ectoines as novel anti-inflammatory and tissue protective lead compounds with special focus on inflammatory bowel disease and lung inflammation. Pharmacol Res 2021;164:105389. [PMID: 33352226 DOI: 10.1016/j.phrs.2020.105389] [Reference Citation Analysis]
33 Janssen KMJ, Hop H, Vissink A, Dijkstra G, de Smit MJ, Brouwer E, Westra J. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease. Int J Environ Res Public Health 2020;17:E8054. [PMID: 33139618 DOI: 10.3390/ijerph17218054] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Cucinotta U, Romano C, Dipasquale V. Diet and Nutrition in Pediatric Inflammatory Bowel Diseases. Nutrients 2021;13:655. [PMID: 33671453 DOI: 10.3390/nu13020655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, Zhang H, Zhang Z, He J, Cui B, Zhang X, Wu Z, Dong M, Cheng W, Tao S, Wei H. Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis. Front Immunol 2022;13:836542. [DOI: 10.3389/fimmu.2022.836542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Reference Citation Analysis]
37 Chen YH, Shin JY, Wei HM, Lin CC, Yu LCH, Liao WT, Chen DC, Chu CL. Prevention of dextran sulfate sodium-induced mouse colitis by the fungal protein Ling Zhi-8 via promoting the barrier function of intestinal epithelial cells. Food Funct 2021;12:1639-50. [PMID: 33481975 DOI: 10.1039/d0fo02604b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Manthey CF, Reher D, Huber S. [What is confirmed in the treatment of chronic inflammatory bowel diseases]. Internist (Berl) 2021. [PMID: 34727190 DOI: 10.1007/s00108-021-01207-6] [Reference Citation Analysis]
39 Xia P, Hou T, Ma M, Li S, Jin H, Luo X, Li J, Geng F, Li B. Konjac oligosaccharides attenuate DSS-induced ulcerative colitis in mice: mechanistic insights. Food Funct 2022;13:5626-39. [PMID: 35506498 DOI: 10.1039/d1fo04004a] [Reference Citation Analysis]
40 Sultan S, El-Mowafy M, Elgaml A, Ahmed TAE, Hassan H, Mottawea W. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease. Front Physiol 2021;12:715506. [PMID: 34646151 DOI: 10.3389/fphys.2021.715506] [Reference Citation Analysis]
41 Turroni F, Milani C, Ventura M, van Sinderen D. The human gut microbiota during the initial stages of life: insights from bifidobacteria. Curr Opin Biotechnol 2021;73:81-7. [PMID: 34333445 DOI: 10.1016/j.copbio.2021.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]